The statement confused experts who said that vaccines aimed at new pathogens have always been tested this way. "That has been ...

Merck is facing an awkward encore as one of the worst-performing blue chip stocks in 2025, sliding 23.3% year-to-date.

Even when equities are volatile, investors can find great stocks to buy. And the rules for investing in the current ...

We recently published a list of Billionaire Mario Gabelli’s 10 Large-Cap Stock Picks with Huge Upside Potential. In this ...

Merck & Co. Inc. managers escaped allegations that they hurt the pharmaceutical giant by misleading investors over traction for its HPV vaccine in China. The plaintiff told Judge Julien Xavier Neals ...

While HHS Secretary Kennedy frets over food dye in Froot Loops, his 2023 attack on Gardasil — a vaccine proven to prevent deadly cancers — reveals a troubling willingness to distort life-saving ...

Merck (NYSE: MRK) recently announced its first ... This underperformance is partly attributable to the issues encountered by its HPV vaccine, Gardasil, in China due to lower demand.

225,000-square-foot manufacturing plant slated to produce bulk substance for its HPV vaccine Gardasil. Merck built the new plant on a 262-acre campus it has occupied since 2004, where the pharma ...

About two months after receiving a sizable taxpayer-funded grant, Merck & Co. officially announced it would build its newest manufacturing facility near Elsmere. A groundbreaking ceremony was held ...

Winrevair and Capvaxive and strong performance of the Animal Health segment were partially offset by lower sales of the HPV vaccine Gardasil in China. Keytruda, the biggest product in Merck’s ...

MerckMRK reported its first-quarter 2025 results last week, beating estimates for both earnings and sales. Adjusted earnings ...